Objective: To assess the efficacy and safety of combined hysteroscopic morcellation/endometrial ablation for treating abnormal uterine bleeding (AUB).
Study Design: Prospective case series from 5 U.S.
Study Objective: To assess the safety and effectiveness of the Minerva Endometrial Ablation System for the treatment of heavy menstrual bleeding in premenopausal women.
Design: Multicenter, randomized, controlled, international study (Canadian Task Force classification I).
Setting: Thirteen academic and private medical centers.
Purpose: To evaluate the efficacy of two cervical block protocols for pain management during hysteroscopic removal of intrauterine polyps and myomas using the MyoSure(®) device.
Patients And Methods: This was a randomized, comparative treatment trial conducted by five private Obstetrics and Gynecology practices in the USA. Forty premenopausal women aged 18 years and older were randomized to receive either a combination para/intracervical block protocol of 37 cc local anesthetic administered at six injections sites in association with the application of topic 1% lidocaine gel, or an intracervical block protocol of 22 cc local anesthetic administered at three injections sites without topical anesthetic, for pain management during hysteroscopic removal of intrauterine polyps and/or a single type 0 or type 1 submucosal myoma ≤3 cm.
Study Objective: To report MiniArc single-incision sling efficacy results in the office setting and the feasibility of performing the procedure in the office.
Design: Prospective, single-arm, nonrandomized, institutional review board-approved study (Canadian Task Force classification II-2).
Setting: Three in-office clinical sites in the United States.